TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Balance Sheet

Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 8,635 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SVA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
239 203 211 211 370 452 1,901 16,748 14,115 13,658 12,337 8,635
155 128 134 131 284 350 1,560 14,915 12,126 11,831 10,645 7,064
91 64 62 62 158 153 1,041 11,609 4,278 1,270 335 1,156
91 64 62 62 177 203 1,176 13,415 11,313 11,223 6,640
41 39 50 50 77 114 253 952 609 451 301 313
19 19 14 14 25 28 106 376 181 140 97 94
68 64 67 76 71 81 284
0.0 0.0 0.0 0.0 28 13
11 9.6 8.7 8.7 8.3 8.0 9.7 41 80 8.5 184 78
97 66 82 82 78 100 781 2,872 1,402 1,635 2,044 2,233
80 58 66 66 58 87 680 2,413 1,092 1,148 1,452 1,540
50 24 34 34 3.3 13 43 15 11 82 233
3.0 1.7 1.8 1.8 5.5 5.8 31 59 20 17 12 16
1.8 0.8 9.4 15 3.9 1.4 8.3 17 12 178 164 265
127 122 130 130 253 294 746 9,327 8,921 8,709 8,262 4,439
-6.4 -10.0 -12 -12 24 57 144 7,142 7,226 7,119 6,838 2,816
56 56 57 57 65 110 114 114 114 100 72 72

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?